首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   372篇
  免费   39篇
  国内免费   1篇
耳鼻咽喉   3篇
儿科学   6篇
妇产科学   12篇
基础医学   43篇
临床医学   43篇
内科学   74篇
皮肤病学   6篇
神经病学   50篇
特种医学   1篇
外科学   74篇
综合类   2篇
预防医学   39篇
药学   28篇
中国医学   1篇
肿瘤学   30篇
  2024年   1篇
  2023年   13篇
  2022年   27篇
  2021年   74篇
  2020年   32篇
  2019年   35篇
  2018年   48篇
  2017年   14篇
  2016年   20篇
  2015年   18篇
  2014年   25篇
  2013年   22篇
  2012年   20篇
  2011年   22篇
  2010年   10篇
  2009年   9篇
  2008年   11篇
  2007年   2篇
  2006年   3篇
  2005年   1篇
  2004年   1篇
  2003年   1篇
  2000年   1篇
  1996年   1篇
  1990年   1篇
排序方式: 共有412条查询结果,搜索用时 62 毫秒
51.
3-Aryl-2-phosphinoimidazo[1,2-a]pyridine ligands were synthesized from 2-aminopyridine via two complementary routes. The first synthetic route involves the copper-catalyzed iodine-mediated cyclizations of 2-aminopyridine with arylacetylenes followed by palladium-catalyzed cross-coupling reactions with phosphines. The second synthetic route requires the preparation of 2,3-diiodoimidazo[1,2-a]pyridine or 2-iodo-3-bromoimidazo[1,2-a]pyridine from 2-aminopyridine followed by palladium-catalyzed Suzuki/phosphination or a phosphination/Suzuki cross-coupling reactions sequence, respectively. Preliminary model studies on the Suzuki synthesis of sterically-hindered biaryl and Buchwald–Hartwig amination compounds are presented with these ligands.

3-Aryl-2-phosphoimidazo[1,2-a]pyridine ligands were prepared via two complimentary synthetic routes and were evaluated in the Suzuki–Miyaura and Buchwald–Hartwig amination cross-coupling reactions.

Palladium-catalyzed cross-coupling reactions have revolutionized the formation of C–C and C–X bond formation in the academic and industrial synthetic organic chemistry sectors.1,2 Applications such as synthesis of natural products,3 active pharmaceutical ingredients (API),4 agrochemicals,5 and materials for electronic applications6 are showcased. Snieckus described in his 2010 Nobel Prize review that privileged ligand scaffolds represented the “third wave” in the cross-coupling reactions where the “first wave” was the investigation of the metal catalyst-the rise of palladium and the “second wave” was the exploration of the organometallic coupling partner.1 In the last twenty years, it was recognized that the choice of ligand facilitated the oxidative addition and reductive-elimination steps of the catalytic cycle of transition metal-catalyzed cross-coupling reactions, increasing the overall rate of the reaction. For example, bulky trialkylphosphines facilitated the oxidative addition processes of electron-rich, unactivated substrates such as aryl chlorides.7,8 Sterically demanding ligands also provided enhanced rates of reductive elimination from [(L)nPd(aryl)(R), R = aryl, amido, phenoxo, etc.] species by alleviation of steric congestion.9 Privileged ligands such as Buchwald''s biarylphosphines,10,11 Fu''s trialkylphosphines,7,8,12 Nolan–Hermann''s N-heterocyclic carbenes (NHC),13–15 Hartwig''s ferrocenes,16,17 Beller''s bis(adamantyl)phosphines18,19 and N-aryl(benz)imidazolyl or N-pyrrolylphosphines,20,21 Zhang''s ClickPhos ligands,22,23 and Stradiotto''s biaryl P–N phosphines,24,25 to mention a few, have found wide-spread use in Suzuki–Miyaura, Corriu–Kumada, Heck, Negishi, Sonogashira, C–X (X = S, O, P) cross-coupling and Buchwald–Hartwig amination reactions (Fig. 1). Preformed catalysts with these ligands attached to the palladium metal center are also recognized as well-defined entities in cross-coupling reactions.26Open in a separate windowFig. 1Privileged ligands for palladium-catalyzed cross-coupling reactions.The term privileged structure was first coined by Evans et al. in 1988 and was defined as “a single molecular framework able to provide ligands for diverse receptors”.27 In the last three decades, it is clear that privileged structures are exploited as opportunities in drug discovery programs.28–31 For example, imidazo[1,2-a]pyridines are privileged structures in medicinal chemistry programs (Fig. 2).32 Imidazo[1,2-a]pyridines are a represented motif in several drugs on the market such as zolpidem, marketed as Ambien™ for the treatment of insomnia,33 minodronic acid, marketed as Bonoteo™ for oral treatment of osteoporosis,34 and olprinone, sold as Coretec™ as a cardiotonic agent.35Open in a separate windowFig. 2Imidazo[1,2-a]pyridines as privileged structures in medicinal chemistry and in our cross-coupling reactions approach.Our group is interested in a long-term research program directed at the use of key privileged structures that are employed in drug discovery programs as potential phosphorus ligands for cross-coupling reactions. In our entry into the use of privileged structures from the medicinal chemistry literature for our investigation into new phosphorus ligands, we have developed two complementary synthetic routes for the preparation of 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligands from 2-aminopyridine as our initial substrate.Our first synthetic route for the preparation of 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligands 3a–3l required the copper(ii) acetate iodine-mediated double oxidative C–H amination of 2-aminopyridine (1) with arylacetylenes under an oxygen atmosphere to give 3-aryl-2-iodoimidazo[1,2-a]pyridines 2a–2d (Scheme 1).36,37Open in a separate windowScheme 1Preparation of 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligands 3a–3l from 2-aminopyridine via copper-catalyzed arylacetylene cyclizations/palladium-catalyzed phosphination reactions sequences.Phenylacetylene and 2-/3-/4-methoxyphenylacetylenes were commercially available reagents. With intermediates 2a–d in hand, we explored several cross-coupling phosphination reactions and we found that palladium-catalyzed phosphination with DIPPF ligand in the presence of cesium carbonate as the base in 1,4-dioxane under reflux provided twelve new ligands 3a–3l as shown in 38 Moderate to good yields were obtained under these cross-coupling conditions. There are few commercially available dimethoxyphenylacetylenes, and most are prohibitively expensive, and so an alternative synthetic strategy was explored.Palladium-catalyzed phosphination of 3-aryl-2-iodoimidazo[1,2-a]pyridines 2a–2da
EntryArR3 (% yield)
1Ph (2a) t-Bu3a (41)
2Ph (2a)Cy3b (50)
3Ph (2a)Ph3c (61)
42-OMeC6H4 (2b) t-Bu3d (53)
52-OMeC6H4 (2b)Cy3e (83)
62-OMeC6H4 (2b)Ph3f (69)
73-OMeC6H4 (2c) t-Bu3g (62)
83-OMeC6H4 (2c)Cy3h (72)
93-OMeC6H4 (2c)Ph3i (79)
104-OMeC6H4 (2d) t-Bu3j (73)
114-OMeC6H4 (2d)Cy3k (55)
124-OMeC6H4 (2d)Ph3l (59)
Open in a separate windowaReaction conditions: 2a–2d (1 equiv.), HPR2 (1 equiv.), Pd(OAc)2 (2 mol%), Cs2CO3 (1.2 equiv.), DIPPF (2.5 mol%), 1,4-dioxane, 80 °C.2-Iodoimidazo[1,2-a]pyridine (4) was conveniently prepared in three steps from 2-aminopyridine (1) following literature procedures, which was then converted into either iodo 5 or bromo 6 with NIS or NBS, respectively (Scheme 2).39,40Open in a separate windowScheme 2Preparation of 2,3-diiodoimidazo[1,2-a]pyridine (5) and 3-bromo-2-iodoimidazo[1,2-a]pyridine (6).When the phosphorus ligands 3 contained tert-butyl or cyclohexyl groups, method 1 was followed where 2,3-diiodoimidazo[1,2-a]pyridine (5) underwent Suzuki cross-coupling reactions with arylboronic acids to yield aryl intermediates 7a–7f, which was followed by palladium-catalyzed cross-coupling phosphination reactions with di-tert-butylphosphine or dicyclohexylphosphine to give C-2 substituted phosphorus ligands 3m–3u in low to moderate yields (Scheme 3, 38 The phosphorus ligands 3v–3ab were prepared from 3-bromo-2-iodoimidazo[1,2-a]pyridine (6) via a palladium-catalyzed phospination with diphenylphosphine (method 2) to give intermediate 8 (X = Br, I becomes PPh2) followed by Suzuki palladium-catalyzed cross-coupling reactions with arylboronic acids. Note that the change in reactivity of the core when switching between bromo and iodo at C3 results in a change in the order of cross-coupling steps.Open in a separate windowScheme 3Preparation of 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligands 3m–3ab from 2-iodo-3-iodo(or bromo)imidazo[1,2-a]pyridines 5 or 6via palladium-catalyzed Suzuki/phosphination or a phosphination/Suzuki cross-coupling reactions sequences.Palladium-catalyzed Suzuki/phosphination or phosphination/Suzuki reactions sequences of 2,3-diiodoimidazo[1,2-a]pyridine (5) or 3-bromo-2-iodoimidazo[1,2-a]pyridine (6)a
EntryRArMethod/substrateStep 1 (% yield)Step 2 (% yield)
1 t-Bu2,3-diOMeC6H31, 57a (59)3m (64)
2 t-Bu3,4-diOMeC6H31, 57b (54)3n (31)
3 t-Bu2,5-diOMeC6H31, 57c (58)3o (61)
4 t-Bu3,4,5-triOMeC6H21, 57d (50)3p (62)
5Cy2,3-diOMeC6H31, 57a (59)3q (46)
6Cy2,6-diOMeC6H31, 57e (40)3r (52)
7Cy3,4-diOMeC6H31, 57b (54)3s (52)
8Cy2,3,4-triOMeC6H21, 57f (58)3t (21)
9Cy3,4,5-triOMeC6H21, 57d (50)3u (55)
10Ph2,3-diOMeC6H32, 68 (70)3v (52)
11Ph2,5-diOMeC6H32, 68 (70)3w (68)
12Ph3,4-diOMeC6H32, 68 (70)3x (67)
13Ph2,3,4-triOMeC6H22, 68 (70)3y (52)
14Ph3,4,5-triOMeC6H22, 68 (70)3z (64)
15Ph4-FC6H42, 68 (70)3aa (40)
16Ph3-F,5-OMeC6H32, 68 (70)3ab (39)
Open in a separate windowaReaction conditions: 5, ArB(OH)2, Pd(PPh3)4 (5 mol%), Na2CO3 (2 equiv.), 1,4-dioxane/H2O (2 : 1) and HPR2 (1 equiv.), Pd(OAc)2 (2.5–5 mol%), Cs2CO3 (1.2 equiv.), DIPPF (2.5–10 mol%), 1,4-dioxane, 80 °C or 6, reverse sequence of reactions.With our library of functionalized imidazo[1,2-a]pyridine phosphorus ligands 3a–3ab in hand, we began to screen these ligands in Suzuki–Miyaura cross-coupling reactions to prepare sterically-hindered biaryl compounds. We chose the Suzuki–Miyaura cross-coupling reactions of m-bromo-xylene (9) and 2-methoxyphenylboronic acid (10) to give 2,6-dimethyl-(2-methoxy)biphenyl (11) as our model reaction as outlined in ii) acetate with 2.5 equivalents of base in 1,4-dioxane at 80 °C for 12–24 h. As expected, SPhos and XPhos were employed as our initial ligands to confirm our GC analyses of >99% conversion in our chosen model reaction (Entries 14–15). With the GC conditions validated, we screened selected ligands from 3a–3ab. It was clearly evident that the di-tert-butyl phosphorus ligands represented by 3a, 3m, and 3p were ineffective ligands in our model reactions (Entries 1–3). Furthermore, the diphenyl phosphorus ligands such as 3w, 3y, 3z, and 3ab showed low to moderate conversions in the model cross-coupling reactions (Entries 6–9). However, the dicyclohexyl phosphorus ligands shown by 3r and 3t showed greater than 99% conversions by GC analyses (Entries 4–5). Further exploration of ligand 3r with K3PO4 as the base, stirring the reaction overnight at room temperature or for 3 h at 80 °C showed inferior conversions (Entries 10–12). There was no conversion when a ligand was not used in the model reaction (Entry 13).Optimization of conditions for the Suzuki–Miyaura cross-coupling model reaction
EntryLigandConditionsConversiona (%)
13a12
23m20
33p14
4 3r >99 b
53t>99
63w21
73y55
83z46
93ab11
103rK3PO4 was used as base reaction was performed at 25 °C reaction was stirred for 3 h no ligand91
113r4
123r39
130
14SPhos>99
15XPhos>99
Open in a separate windowaBased on GC analyses of consumed 9.bIsolated yield of 96% was obtaisned.Furthermore, a Buchwald–Hartwig amination model study was investigated with our new imidazo[1,2-a]pyridine phosphorus ligands 3a–3ab. The Buchwald–Hartwig amination reaction of 4-chlorotoluene (12) with aniline (13) to give 4-methyl-N-phenylaniline (14) was screened with our ligands (
EntryLigandConditionsConversiona (%)
13a38
23d26
3 3e >99 b
43g29
53h54
63k71
73n0
83p0
93q>99
103r92
113s>99
123sK3PO4 was used as base83
133sK2CO3 was used as base0
143sKOt-Bu was used as base>99
153sNaOt-Bu was used as base>99
Open in a separate windowaBased on GC analyses of consumed 13.bIsolated yield of 76% was obtained.In summary, we have disclosed two complementary synthetic routes to 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligands 3a–3ab from 2-aminopyridine (1). In one method, 2-aminopyridine (1) underwent a copper-catalyzed iodine-mediated cyclization with arylacetylenes followed by palladium-catalyzed cross-coupling reactions with phosphines. In the second protocol, 2,3-diiodoimidazo[1,2-a]pyridine (5) or 3-bromo-2-iodoimidazo[1,2-a]pyridine (6) were prepared from 2-aminopyridine (1) followed by palladium-catalyzed phosphination/Suzuki or Suzuki/phosphination reactions sequences, respectively. We are currently exploring the scope and limitations of the 3-aryl-2-phosphinoimidazo[1,2-a]pyridine ligand 3r and 3e in our Suzuki–Miyaura and Buchwald–Hartwig amination cross-coupling reactions, respectively.  相似文献   
52.
RT-PCR Increases Detection of Submicroscopic Peritoneal Metastases in Gastric Cancer and Has Prognostic Significance     
Wong J  Kelly KJ  Mittra A  Gonen M  Allen P  Fong Y  Coit D 《Journal of gastrointestinal surgery》2012,16(5):889-896

Background  

Positive peritoneal cytology confers the same prognosis as clinical stage IV disease in gastric cancer. Conventional cytology examination, however, has low sensitivity. We hypothesize that real-time polymerase chain reaction (RT-PCR) may have increased sensitivity and provide more accurate staging information.  相似文献   
53.
Clinical practice guidelines—Nursing management for pediatric patients with small bowel or multivisceral transplant     
Cynthia Bodeur BSN  RN  CPN  Julia Aucoin DNS  RN‐BC  CNE  Raeanne Johnson BSN  RN  CPN  Kaitlyn Garrison BSN  RN  CPN  Amanda Summers BSN  RN  CPN  Kristen Schutz RN  Megan Davis DNP  RN  CPNP‐PC  Sherri Woody MSN  RN  CPN  Kelly Ellington BSN  RN 《Journal for specialists in pediatric nursing》2014,19(1):90-100
  相似文献   
54.
A rehabilitation exercise program to remediate skeletal muscle atrophy in an estrogen-deficient organism may be ineffective     
Brown M  Ferreira JA  Foley AM  Hemmann KM 《European journal of applied physiology》2012,112(1):91-104
To determine rehabilitation exercise program effects under hormone deficient (ovariectomy or OVX) and hormone supplemented [OVX + 17-beta estradiol (E2)] conditions. Mature female rats (n = 123) were assigned to OVX or OVX + E2-supplemented groups. OVX and OVX + E2 groups were allocated to one of four conditions: (1) control, (2) hindlimb unweighted (HLU) for 4 weeks to induce muscle atrophy, (3) cage Recovery for 2 weeks after HLU, and (4) Recovery with 2 weeks of rehabilitation exercise program after 4 weeks of HLU. Atrophy following HLU was comparable for OVX and OVX + E2-supplemented rats and was significant in all muscles examined (soleus, tibialis anterior, plantaris, gastrocnemius, quadriceps). Also significant with HLU was the decline in muscle force (P < 0.05) in soleus, plantaris, gastrocnemius and tibialis anterior (quadriceps not tested). There were trends toward return of muscle mass in Recovery OVX and Recovery OVX + E2 groups but only the E2 supplemented OVX rats had return of muscle mass (4/5 muscles studied) with exercise. Peak tetanic tension (Po) returned to control values in the E2 supplemented Exercise rats but not in the unsupplemented Exercise group. For example, gastrocnemius Po for OVX HLU, OVX Recovery and OVX-Exercise groups was 82%*, 82%* and 76%* of control. Gastrocnemius Po for E2 supplemented HLU, Recovery and Exercise groups was 72%*, 95% and 106% of control (*P < 0.05 compared to control). H&E cross-sections from OVX-Exercise rats showed central nuclei. In conclusion, a rehabilitation exercise program to remediate acute atrophy in females appears more effective if E2 is present.  相似文献   
55.
Role of aberrant PI3K pathway activation in gallbladder tumorigenesis     
Andrea Lunardi  Kaitlyn A. Webster  Antonella Papa  Bhavik Padmani  John G. Clohessy  Roderick T. Bronson  Pier Paolo Pandolfi 《Oncotarget》2014,5(4):894-900
The PI3K/AKT pathway governs a plethora of cellular processes, including cell growth, proliferation, and metabolism, in response to growth factors and cytokines. By acting as a unique lipid phosphatase converting phosphatidylinositol-3,4,5,-trisphosphate (PIP3) to phosphatidylinositol-4,5,-bisphosphate (PIP2), phosphatase and tensin homolog (PTEN) acts as the major cellular suppressor of PI3K signaling and AKT activation. Recently, PI3K mutations and loss/mutation of PTEN have been characterized in human gallbladder tumors; whether aberrant PTEN/PI3K pathway plays a causal role in gallbladder carcinogenesis, however, remains unknown. Herein we show that in mice, deregulation of PI3K/AKT signaling is sufficient to transform gallbladder epithelial cells and trigger fully penetrant, highly proliferative gallbladder tumors characterized by high levels of phospho-AKT. Histopathologically, these mouse tumors faithfully resemble human adenomatous gallbladder lesions. The identification of PI3K pathway deregulation as both an early event in the neoplastic transformation of the gallbladder epithelium and a main mechanism of tumor growth in Pten heterozygous and Pten mutant mouse models provides a new framework for studying in vivo the efficacy of target therapies directed against the PI3K pathway, as advanced metastatic tumors are often addicted to “trunkular” mutations.  相似文献   
56.
Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases     
Cassandra L. Chatwin  Jodie C. Hamrick  Robert E. L. Trout  Cullen L. Myers  Susan M. Cusick  William J. Weiss  Mark E. Pulse  Luigi Xerri  Christopher J. Burns  Gregory Moeck  Denis M. Daigle  Kaitlyn John  Tsuyoshi Uehara  Daniel C. Pevear 《Antimicrobial agents and chemotherapy》2021,65(8)
  相似文献   
57.
Draft genome of the red harvester ant Pogonomyrmex barbatus   总被引:3,自引:0,他引:3  
Smith CR  Smith CD  Robertson HM  Helmkampf M  Zimin A  Yandell M  Holt C  Hu H  Abouheif E  Benton R  Cash E  Croset V  Currie CR  Elhaik E  Elsik CG  Favé MJ  Fernandes V  Gibson JD  Graur D  Gronenberg W  Grubbs KJ  Hagen DE  Viniegra AS  Johnson BR  Johnson RM  Khila A  Kim JW  Mathis KA  Munoz-Torres MC  Murphy MC  Mustard JA  Nakamura R  Niehuis O  Nigam S  Overson RP  Placek JE  Rajakumar R  Reese JT  Suen G  Tao S  Torres CW  Tsutsui ND  Viljakainen L  Wolschin F  Gadau J 《Proceedings of the National Academy of Sciences of the United States of America》2011,108(14):5667-5672
We report the draft genome sequence of the red harvester ant, Pogonomyrmex barbatus. The genome was sequenced using 454 pyrosequencing, and the current assembly and annotation were completed in less than 1 y. Analyses of conserved gene groups (more than 1,200 manually annotated genes to date) suggest a high-quality assembly and annotation comparable to recently sequenced insect genomes using Sanger sequencing. The red harvester ant is a model for studying reproductive division of labor, phenotypic plasticity, and sociogenomics. Although the genome of P. barbatus is similar to other sequenced hymenopterans (Apis mellifera and Nasonia vitripennis) in GC content and compositional organization, and possesses a complete CpG methylation toolkit, its predicted genomic CpG content differs markedly from the other hymenopterans. Gene networks involved in generating key differences between the queen and worker castes (e.g., wings and ovaries) show signatures of increased methylation and suggest that ants and bees may have independently co-opted the same gene regulatory mechanisms for reproductive division of labor. Gene family expansions (e.g., 344 functional odorant receptors) and pseudogene accumulation in chemoreception and P450 genes compared with A. mellifera and N. vitripennis are consistent with major life-history changes during the adaptive radiation of Pogonomyrmex spp., perhaps in parallel with the development of the North American deserts.  相似文献   
58.
Relationships between parent–child social media interactions and health behaviors     
Caitlin C. Abar  Sarah Farnett  Kayla Mendola  Kaitlyn Koban  Sharon Sarra 《Journal of substance use》2018,23(3):335-337
Social media use by both teens and adults has become increasingly common. This frequency of interaction can be capitalized upon by researchers looking to design programs to limit youth substance use. This study serves as a first step in this area of research, examining how parent–child social media exchanges (specifically on Facebook) may be related to youth risk behavior. In a sample of 252 college students, results indicated that roughly 63% of youth reported being friends with their parents on Facebook while in high school. A minority (27%) reported they blocked their parents from seeing certain material on their Facebook page, and most youth reported their parents discussed information from their Facebook page with some regularity (65%). Logistic regression analyses indicated that, when accounting for demographics, parental solicitation, and parental control efforts, youth who were friends with their parents on Facebook and did not block any materials from them had a decreased likelihood of alcohol and/or marijuana use in high school relative to those who were not friends with their parents on Facebook or who blocked materials from their parents. These findings imply that efforts to encourage parent–child interactions via social media may help prevent substance use in high school.  相似文献   
59.
Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A     
Andreas Nikolis  Kaitlyn M. Enright  Christina Rudolph  Sebastian Cotofana 《Journal of Cosmetic Dermatology》2020,19(6):1294-1300
  相似文献   
60.
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation          下载免费PDF全文
Amir T. Fathi MD  Traci M. Blonquist  Daniela Hernandez  Philip C. Amrein MD  Karen K. Ballen MD  Malgorzata McMasters MD  David E. Avigan MD  Robin Joyce MD  Emma K. Logan  Gabriela Hobbs MD  Andrew M. Brunner MD  Christelle Joseph  Ashley M. Perry  Meghan Burke  Tanya Behnan  Julia Foster  Meghan K. Bergeron  Jenna A. Moran  Aura Y. Ramos  Tina T. Som  Jessica Rae  Kaitlyn M. Fishman  Kristin L. McGregor  Christine Connolly  Donna S. Neuberg  Mark J. Levis MD 《Cancer》2018,124(2):306-314
  相似文献   
[首页] « 上一页 [1] [2] [3] [4] [5] 6 [7] [8] [9] [10] [11] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号